| Press Release | Grifols XEMBIFY receives European approvals, expanding access to innovative therapies | Grifols | 0 | 3 years 2 weeks ago |
| Press Release | Grifols partners with Feeding America to help address hunger in the U.S. | Grifols | 0 | 3 years 3 weeks ago |
| Press Release | Grifols signs global collaboration agreement with Endpoint Health to develop and commercialize Antithrombin III for Sepsis | Grifols | 0 | 3 years 1 month ago |
| Press Release | Grifols Egypt begins taking plasma donations | Grifols | 0 | 3 years 2 months ago |
| Press Release | Grifols acquires its first plasma donation center in Canada | Grifols | 0 | 3 years 2 months ago |
| Press Release | Grifols receives first certifications for new In Vitro Diagnostics Medical Devices European Regulation | Grifols | 0 | 3 years 3 months ago |
| Press Release | Grifols reaches milestone with 300th U.S. plasma donor center, continuing to increase supply of urgently needed plasma | Grifols | 0 | 3 years 3 months ago |
| Press Release | Grifols launches new home-care treatment service for patients with alpha-1 antitrypsin deficiency in Spain | Grifols | 0 | 3 years 4 months ago |
| Press Release | Grifols and GIC obtain authorization for their strategic agreement for USD 1 billion | Grifols | 0 | 3 years 4 months ago |
| Press Release | Grifols is included on the Dow Jones Sustainability World Index | Grifols | 0 | 3 years 4 months ago |
| Press Release | Grifols earns approval for the voluntary public tender offer of Biotest and advances its strategy to increase the availability of plasma-derived medicines | Grifols | 0 | 3 years 5 months ago |
| Press Release | Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines | Grifols | 0 | 3 years 5 months ago |
| Press Release | Grifols closes its EUR 2 billion bond issuance to finance its investment in Biotest | Grifols | 0 | 3 years 5 months ago |
| Press Release | GigaGen Licenses ProteoNics 2G UNic Technology Platform for High Yield Production of GigaGens Mono- and Polyclonal Antibody Drug Candidates | Grifols | 0 | 3 years 5 months ago |
| Press Release | Grifols begins commercializing TAVLESSE in France, Italy and Spain to treat chronic immune thrombocytopenia | Grifols | 0 | 3 years 6 months ago |
| Press Release | Grifols earns its first Fitch corporate rating with a BB- and stable outlook | Grifols | 0 | 3 years 6 months ago |
| Press Release | GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 for COVID-19 | Grifols | 0 | 3 years 7 months ago |
| Press Release | Grifols advances on its strategic investment from GIC with 90% of consents from its notes holders and lenders | Grifols | 0 | 3 years 7 months ago |
| Press Release | Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan | Grifols | 0 | 3 years 7 months ago |
| Press Release | Alkahest Strengthens Management Team with Addition of Cesar Cerezo as Chief Medical Officer | Grifols | 0 | 3 years 8 months ago |
| Press Release | Grifols endorses its commitment to a responsible business model and support of the 2030 Agenda for Sustainable Development by formally joining the United Nations Global Compact | Grifols | 0 | 3 years 8 months ago |
| Press Release | Grifols further expands its activity in Africa with agreement to set up an intravenous solutions manufacturing plant in Nigeria | Grifols | 0 | 3 years 8 months ago |
| Press Release | GigaGen Publishes Research Describing Novel Mechanism of Action and Therapeutic Potential of its anti-CTLA-4 Drug Candidate, GIGA-564 | Grifols | 0 | 3 years 8 months ago |
| Press Release | Grifols becomes official partner of UEFA Womens Football | Grifols | 0 | 3 years 8 months ago |
| Press Release | Grifols announces a strategic investment from GIC of USD 1 billion | Grifols | 0 | 3 years 8 months ago |
